Application: WB, ICC, IHC
Clonality: Monoclonal
Host: Mouse
Reactivity: Human
Protein Description: poly (ADP-ribose) polymerase 1
Gene Name: PARP1
Alternative Gene Name: ADPRT, PARP, PPOL
Clone ID: CL2220
Isotype: IgG1
Interspecies mouse/rat: ENSMUSG00000026496: 95%, ENSRNOG00000003084: 94%
Entrez Gene ID: 142
Uniprot ID: P09874
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Clonality: Monoclonal
Host: Mouse
Reactivity: Human
Protein Description: poly (ADP-ribose) polymerase 1
Gene Name: PARP1
Alternative Gene Name: ADPRT, PARP, PPOL
Clone ID: CL2220
Isotype: IgG1
Interspecies mouse/rat: ENSMUSG00000026496: 95%, ENSRNOG00000003084: 94%
Entrez Gene ID: 142
Uniprot ID: P09874
Buffer: 40% glycerol and PBS (pH 7.2). 0.02% sodium azide is added as preservative.
Storage Temperature: Store at +4°C for short term storage. Long time storage is recommended at -20°C.
Documents & Links for Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) | |
Datasheet | Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) at Atlas |
Documents & Links for Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) | |
Datasheet | Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) Datasheet (External Link) |
Vendor Page | Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) |
Citations for Anti PARP1 mAb (Clone CL2220, ATL-AMAb90959 w/enhanced validation) – 3 Found |
RAD51-Mediated DNA Homologous Recombination Is Independent of PTEN Mutational Status. Cancers (Basel). 2020 Oct 29;12(11):3178. doi: 10.3390/cancers12113178. PubMed |
Revealing protein-protein interactions at the transcriptome scale by sequencing. Mol Cell. 2021 Oct 7;81(19):4091-4103.e9. doi: 10.1016/j.molcel.2021.07.006. Epub 2021 Aug 3. PubMed |
PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer. EJNMMI Res. 2022 Sep 14;12(1):60. doi: 10.1186/s13550-022-00932-9. PubMed |